File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non-Small-Cell Lung Cancer (NSCLC)

TitleReport From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non-Small-Cell Lung Cancer (NSCLC)
Authors
KeywordsElective nodal irradiation
Non-small-cell lung cancer
Involved-field irradiation
Isolated nodal failure
Issue Date2008
Citation
International Journal of Radiation Oncology Biology Physics, 2008, v. 72, n. 2, p. 335-342 How to Cite?
AbstractLymphatic spread is an important pathway of progression in non-small-cell lung cancer (NSCLC), along with local spread and distant metastasis. The probability of lymph node (LN) involvement is dependent on the site of the primary tumor, stage, and histology. Elective nodal irradiation (ENI) is the irradiation of clinical and radiological uninvolved LN to account for microscopic tumor invasion in these LNs because we have not been able to determine the extent of LN spread accurately. The clinical value of ENI is uncertain. The impact of ENI is dependent on many (staging-, treatment-, and patient-related) factors. The purpose of this report is to analyze the current status of ENI and to provide comprehensive in-depth analysis and guidance on how to generally approach this issue in NSCLC. © 2008 Elsevier Inc. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/266886
ISSN
2023 Impact Factor: 6.4
2023 SCImago Journal Rankings: 1.992
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorBelderbos, José S.A.-
dc.contributor.authorKepka, Lucyna-
dc.contributor.author(Spring) Kong, Feng Ming-
dc.contributor.authorMartel, Mary K.-
dc.contributor.authorVidetic, Gregory M.M.-
dc.contributor.authorJeremic, Branislav-
dc.date.accessioned2019-01-31T07:19:53Z-
dc.date.available2019-01-31T07:19:53Z-
dc.date.issued2008-
dc.identifier.citationInternational Journal of Radiation Oncology Biology Physics, 2008, v. 72, n. 2, p. 335-342-
dc.identifier.issn0360-3016-
dc.identifier.urihttp://hdl.handle.net/10722/266886-
dc.description.abstractLymphatic spread is an important pathway of progression in non-small-cell lung cancer (NSCLC), along with local spread and distant metastasis. The probability of lymph node (LN) involvement is dependent on the site of the primary tumor, stage, and histology. Elective nodal irradiation (ENI) is the irradiation of clinical and radiological uninvolved LN to account for microscopic tumor invasion in these LNs because we have not been able to determine the extent of LN spread accurately. The clinical value of ENI is uncertain. The impact of ENI is dependent on many (staging-, treatment-, and patient-related) factors. The purpose of this report is to analyze the current status of ENI and to provide comprehensive in-depth analysis and guidance on how to generally approach this issue in NSCLC. © 2008 Elsevier Inc. All rights reserved.-
dc.languageeng-
dc.relation.ispartofInternational Journal of Radiation Oncology Biology Physics-
dc.subjectElective nodal irradiation-
dc.subjectNon-small-cell lung cancer-
dc.subjectInvolved-field irradiation-
dc.subjectIsolated nodal failure-
dc.titleReport From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non-Small-Cell Lung Cancer (NSCLC)-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.ijrobp.2008.04.081-
dc.identifier.pmid18793953-
dc.identifier.scopuseid_2-s2.0-51449089269-
dc.identifier.volume72-
dc.identifier.issue2-
dc.identifier.spage335-
dc.identifier.epage342-
dc.identifier.isiWOS:000259329800006-
dc.identifier.issnl0360-3016-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats